Nova Leap Health Corp.
NVLPF
$0.1856
-$0.0044-2.32%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.60% | -2.58% | -4.15% | -4.00% | -7.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.60% | -2.58% | -4.15% | -4.00% | -7.18% |
| Cost of Revenue | -3.27% | -6.11% | -8.00% | -7.75% | -9.98% |
| Gross Profit | 1.21% | 3.63% | 2.73% | 2.82% | -2.08% |
| SG&A Expenses | 0.19% | -4.73% | -8.15% | -12.09% | -13.00% |
| Depreciation & Amortization | -34.04% | -37.68% | -40.15% | -36.35% | -34.72% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.20% | -6.85% | -9.39% | -10.47% | -12.12% |
| Operating Income | 87.68% | 636.24% | 292.70% | 179.32% | 143.33% |
| Income Before Tax | 232.65% | 65.90% | 112.46% | 61.81% | -13.22% |
| Income Tax Expenses | 239.25% | 94.84% | 109.16% | 62.08% | 16.05% |
| Earnings from Continuing Operations | 230.70% | 56.79% | 113.95% | 61.68% | -26.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 230.70% | 56.79% | 113.95% | 61.68% | -26.21% |
| EBIT | 87.68% | 636.24% | 292.70% | 179.32% | 143.33% |
| EBITDA | 6.15% | 99.97% | 171.77% | 924.79% | 449.57% |
| EPS Basic | 230.33% | 55.28% | 113.13% | 58.02% | -27.08% |
| Normalized Basic EPS | 2,200.00% | 203.51% | 334.15% | 256.25% | 86.79% |
| EPS Diluted | 223.81% | 58.02% | 108.74% | 55.29% | -26.00% |
| Normalized Diluted EPS | 2,200.00% | 203.51% | 328.57% | 251.52% | 87.04% |
| Average Basic Shares Outstanding | 0.75% | 0.70% | 2.25% | 3.98% | 5.84% |
| Average Diluted Shares Outstanding | 0.83% | 0.77% | 2.06% | 3.77% | 5.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |